Gaspar J. Kitange

Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts

Gaspar J. Kitange, Brett L. Carlson, Mark A. Schroeder et al. · Neuro-Oncology · 2008 · 388 citations · Full text

Medicine, Cancer Biology, Oncology +17

A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma

Xiaoyue Chen, Minjie Zhang, Haiyun Gan et al. · Nature Communications · 2018 · 283 citations · Full text

Medicine, Cancer Biology, Oncology +17

Use of an Orthotopic Xenograft Model for Assessing the Effect of Epidermal Growth Factor Receptor Amplification on Glioblastoma Radiation Response

Jann N. Sarkaria, Brett L. Carlson, Mark A. Schroeder et al. · Clinical Cancer Research · 2006 · 279 citations

Medicine, Oncology, Radiation Oncology +16

Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177

Paul D. Brown, Sunil Krishnan, Jann N. Sarkaria et al. · Journal of Clinical Oncology · 2008 · 275 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma

Rachael A. Vaubel, Shulan Tian, Dioval Remonde et al. · Clinical Cancer Research · 2019 · 239 citations · Full text

Medicine, Genetics, Oncology +17